Researcher Profile

Spencer A. Knapp, PhD

Associate II Member, Clinical Investigations and Precision Therapeutics Program

Member since 2009

Academic Appointment

Professor of Chemistry and Chemical Biology
School of Arts and Sciences
Rutgers, The State University of New Jersey


Research Interests

  • We design enzyme inhibitors based on biomimetic and mechanistic principles. Recent systems examined include selenoglutamate and boraglutamate derivatives, GlcNAc-thiazoline and thiosulfonate based inhibitors of N-acetylhexosaminidases, and a seleninic acid tyrosine phosphate mimic that irreversibly inhibits protein tyrosine phosphatases

Selected Publications

The content for this Researcher Profile is maintained by Paul Novembre (


precision medicine at Rutgers Cancer Institute







Donate Now








Proud member of
Big Ten Cancer Research Consortium



Rutgers Health